Nitroglycerin tolerance: Different mechanisms in vascular segments with or without intact endothelial function

Journal of Cardiovascular Pharmacology

Volumn 40, Issue 2, 2002, Pages 201-209

  Gruhn, Nicolai ^a   Boesgaard, Søren ^a   Andersen, Claus ^a   Aldershvile, Jan ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Endothelium; Losartan; Nitroglycerin tolerance; Superoxide anion; Superoxide dismutase

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; LOSARTAN; SUPEROXIDE; SUPEROXIDE DISMUTASE; ACETYLCHOLINE; ANTIHYPERTENSIVE AGENT; VASODILATOR AGENT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG TOLERANCE; MALE; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; VASCULAR ENDOTHELIUM; ANIMAL; DRUG EFFECT; DRUG INTERACTION; METABOLISM; VASODILATATION; WISTAR RAT;

ACETYLCHOLINE; ANIMAL; ANTIHYPERTENSIVE AGENTS; DRUG INTERACTIONS; DRUG TOLERANCE; ENDOTHELIUM, VASCULAR; LOSARTAN; MALE; NITROGLYCERIN; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; SUPPORT, NON-U.S. GOV'T; VASODILATION; VASODILATOR AGENTS; ANIMALS;

EID: 0035988138     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200208000-00005     Document Type: Article

References (31)

1. Antianginal effects of intravenous nitroglycerin over 24 hours
2. Prevention and reversal of nitrate tolerance in patients with congestive heart failure
3. Hemodynamic and volumetric effects of venodilation with nitroglycerin in chronic mitral regurgitation
4. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates
5. Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells
6. Biotransformation of organic nitrates to nitric oxide by vascular smooth muscle and endothelial cells
7. Mechanism of tolerance development to organic nitrates
8. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: Role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetyl-cysteine
9. Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin
10. Desensitization to nitroglycerin in vascular smooth muscle from rat and human
11. Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover
12. Evidence for enhanced vascular superoxide anion production in nitrate tolerance: A novel mechanism underlying tolerance and cross-tolerance
13. In vivo nitrate tolerance is not associated with reduced bioconversion of nitroglycerin to nitric oxide
14. Nitrate tolerance: Effect of thiol supplementation during prolonged nitroglycerin infusion in an in vivo rat model
15. Circulatory system
16. Nitrate tolerance in vivo is not associated with depletion of arterial or venous thiol levels
17. Nitroglycerin-mediated vasorelaxation is modulated by endothelial calcium-activated potassium channels
18. A strain-gauge myograph for isometric measurements of tension in isolated small blood vessels and other muscle preparations
19. PEG-SOD and myocardial protection: Studies in the blood- and crystalloid-perfused rabbit and rat hearts
20. Evidence for a causal role of the renin-angiotensin system in nitrate tolerance
21. Role of superoxide dismutase in in vivo and in vitro nitrate tolerance
22. Endothelial modulation of the coronary vasculature in vessels perfused via mature collaterals
23. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo
24. Effects of a nitrate-free interval on tolerance, vasoconstrictor sensitivity and vascular superoxide production
25. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans
26. Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis
27. Nitroglycerin-induced coronary vasodilation is not enhanced in patients with impaired endothelium-dependent dilation
28. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability
29. Nitroglycerin tolerance in human vessels: Evidence for impaired nitroglycerin bioconversion
30. Possible involvement of nitroglycerin converting step in nitroglycerin tolerance
31. Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover